Benchmark dose risks assesment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
| Tag | 1 | 2 | Value |
|---|---|---|---|
| LDR | 00000nab a2200000 i 4500 | ||
| 001 | MAP20071504061 | ||
| 003 | MAP | ||
| 005 | 20080418124108.0 | ||
| 007 | hzruuu---uuuu | ||
| 008 | 030722e20030601usa|||| | |00010|eng d | ||
| 040 | $aMAP$bspa | ||
| 084 | $a872 | ||
| 245 | 1 | 0 | $aBenchmark dose risks assesment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses$cSchlosser, Paul M., ... [et al] |
| 520 | 8 | $aThis article presents the later approach, the purpose of which is to combine BMD and pharmacokinetic modeling to estimate human cancer risks from formaldehyde exposure. | |
| 650 | 1 | $0MAPA20080627553$aRiesgos higiénicos industriales | |
| 650 | 0 | 1 | $0MAPA20080540500$aCáncer |
| 650 | 1 | 1 | $0MAPA20080594015$aToxicología laboral |
| 650 | 1 | 1 | $0MAPA20080562595$aFormaldehido |
| 650 | 1 | 1 | $0MAPA20080619480$aEnfermedades profesionales |
| 650 | 0 | 1 | $0MAPA20080601522$aEvaluación de riesgos |
| 650 | 1 | 1 | $0MAPA20080585679$aHigiene industrial |
| 700 | 1 | $0MAPA20080254889$aScholosser, Paul M. | |
| 773 | 0 | $wMAP20077000345$tRisk analysis : an international journal$dNew York and London : Society for Risk Analysis$gVol. 23, nº 3, June, 2003 ; p. 473-487 |